Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Effects of renal denervation on coronary flow reserve and forearm dilation capacity in patients with treatment-resistant hypertension. A randomized, double-blinded, sham-controlled clinical trial.

Engholm M, Bertelsen JB, Mathiassen ON, Bøtker HE, Vase H, Peters CD, Bech JN, Buus NH, Schroeder AP, Rickers H, Hansen KW, Poulsen PL, Kaltoft A, Christensen KL.

Int J Cardiol. 2018 Jan 1;250:29-34. doi: 10.1016/j.ijcard.2017.09.200. Epub 2017 Oct 1.

PMID:
29042091
2.

The effect of renal denervation on arterial stiffness, central blood pressure and heart rate variability in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET trial).

Peters CD, Mathiassen ON, Vase H, Bech Nørgaard J, Christensen KL, Schroeder AP, Rickers HJVH, Opstrup UK, Poulsen PL, Langfeldt S, Andersen G, Hansen KW, Bøtker HE, Engholm M, Bertelsen JB, Pedersen EB, Kaltoft A, Buus NH.

Blood Press. 2017 Dec;26(6):366-380. doi: 10.1080/08037051.2017.1368368. Epub 2017 Aug 23.

PMID:
28830251
3.

Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.

Mathiassen ON, Vase H, Bech JN, Christensen KL, Buus NH, Schroeder AP, Lederballe O, Rickers H, Kampmann U, Poulsen PL, Hansen KW, Btker HE, Peters CD, Engholm M, Bertelsen JB, Lassen JF, Langfeldt S, Andersen G, Pedersen EB, Kaltoft A.

J Hypertens. 2016 Aug;34(8):1639-47. doi: 10.1097/HJH.0000000000000977.

4.

Small artery structure during antihypertensive therapy is an independent predictor of cardiovascular events in essential hypertension.

Buus NH, Mathiassen ON, Fenger-Grøn M, Præstholm MN, Sihm I, Thybo NK, Schroeder AP, Thygesen K, Aalkjær C, Pedersen OL, Mulvany MJ, Christensen KL.

J Hypertens. 2013 Apr;31(4):791-7. doi: 10.1097/HJH.0b013e32835e215e.

PMID:
23325394
5.

Coprinus cinereus rad50 mutants reveal an essential structural role for Rad50 in axial element and synaptonemal complex formation, homolog pairing and meiotic recombination.

Acharya SN, Many AM, Schroeder AP, Kennedy FM, Savytskyy OP, Grubb JT, Vincent JA, Friedle EA, Celerin M, Maillet DS, Palmerini HJ, Greischar MA, Moncalian G, Williams RS, Tainer JA, Zolan ME.

Genetics. 2008 Dec;180(4):1889-907. doi: 10.1534/genetics.108.092775. Epub 2008 Oct 20.

6.

Small artery structure is an independent predictor of cardiovascular events in essential hypertension.

Mathiassen ON, Buus NH, Sihm I, Thybo NK, Mørn B, Schroeder AP, Thygesen K, Aalkjaer C, Lederballe O, Mulvany MJ, Christensen KL.

J Hypertens. 2007 May;25(5):1021-6.

PMID:
17414666
7.

Intraventricular dispersion and temporal delay of early left ventricular filling after acute myocardial infarction. Assessment by magnetic resonance velocity mapping.

Houlind K, Schroeder AP, Stødkilde-Jørgensen H, Paulsen PK, Egeblad H, Pedersen EM.

Magn Reson Imaging. 2002 Apr;20(3):249-60.

PMID:
12117607
8.

Biplane long-axis magnetic resonance imaging. Survey projections for rapid estimation of left ventricular mass and global function.

Schroeder AP, Houlind K, Pedersen EM, Nielsen TT, Egeblad H.

Scand Cardiovasc J. 2001 Dec;35(6):385-93.

PMID:
11837518
9.

Serial magnetic resonance imaging of global and regional left ventricular remodeling during 1 year after acute myocardial infarction.

Schroeder AP, Houlind K, Pedersen EM, Nielsen TT, Egeblad H.

Cardiology. 2001;96(2):106-14.

PMID:
11740140
10.

Bedside coagulometry during intravenous heparin therapy after coronary angioplasty.

Schroeder AP, Knudsen LL, Husted SE, Knudsen L, Ingerslev J.

J Thromb Thrombolysis. 2001 Oct;12(2):157-63.

PMID:
11729367
11.

Magnetic resonance imaging seems safe in patients with intracoronary stents.

Schroeder AP, Houlind K, Pedersen EM, Thuesen L, Nielsen TT, Egeblad H.

J Cardiovasc Magn Reson. 2000;2(1):43-9.

PMID:
11545106
12.

Percutaneous transluminal coronary angioplasty versus thrombolysis in acute myocardial infarction.

Hansen HH, Thuesen L, Rasmussen K, Andersen HR, Vesterlund T, Villadsen AB, Schroeder AP, Husted SE, Nielsen TT.

Scand Cardiovasc J. 2000 Aug;34(4):365-70.

PMID:
10983669
13.

Age-dependent changes in spatial and temporal blood velocity distribution of early left ventricular filling.

Houlind K, Schroeder AP, Egeblad H, Pedersen EM.

Magn Reson Imaging. 1999 Jul;17(6):859-68.

PMID:
10402593
14.

Clinical assessment of indication for ACE-inhibitor treatment early after acute myocardial infarction.

Schroeder AP, Sørensen K, Nielsen JC, Rehling M, Flø C, Sand NP, Egeblad H.

Scand Cardiovasc J. 1999;33(3):137-42.

PMID:
10399800
15.

[Percutaneous transluminal coronary angioplasty in acute myocardial infarction. A prospective controlled study].

Thuesen L, Rasmussen K, Andersen HR, Nielsen TV, Villadsen AB, Hansen HH, Schroeder AP, Husted SE, Nielsen TT.

Ugeskr Laeger. 1998 Sep 7;160(37):5344-8. Danish.

PMID:
9748859
16.

Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens.

Sihm I, Schroeder AP, Aalkjaer C, Mulvany MJ, Thygesen K, Lederballe O.

Am J Hypertens. 1998 Mar;11(3 Pt 1):263-71.

PMID:
9544865
17.

Heart function in patients with chronic glomerulonephritis and mildly to moderately impaired renal function. An echocardiographic study.

Schroeder AP, Kristensen BO, Nielsen CB, Pedersen EB.

Blood Press. 1997 Sep;6(5):286-93.

PMID:
9359999
18.

Myocardial ischemia and ventricular arrhythmias in relation to left ventricular mass and resistance artery structure.

Sihm I, Søgaard P, Schroeder AP, Aalkjaer C, Mulvany M, Lederballe O, Thygesen K.

Cardiology. 1997 Mar-Apr;88(2):141-6.

PMID:
9096913
20.

Pathophysiology and inflammatory aspects of plaque rupture.

Schroeder AP, Falk E.

Cardiol Clin. 1996 May;14(2):211-20. Review.

PMID:
8724553
21.

Influence of humoral and neurohormonal factors on cardiovascular hypertrophy in untreated essential hypertensives.

Schroeder AP, Sihm I, Mørn B, Thygesen K, Pedersen EB, Lederballe O.

Am J Hypertens. 1996 Mar;9(3):207-15.

PMID:
8695018
22.

Vulnerable and dangerous coronary plaques.

Schroeder AP, Falk E.

Atherosclerosis. 1995 Dec;118 Suppl:S141-9. Review.

PMID:
8821473
23.
24.

The relation between peripheral vascular structure, left ventricular hypertrophy, and ambulatory blood pressure in essential hypertension.

Sihm I, Schroeder AP, Aalkjaer C, Holm M, Mørn B, Mulvany M, Thygesen K, Lederballe O.

Am J Hypertens. 1995 Oct;8(10 Pt 1):987-96.

PMID:
8845080
25.

Normalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE-inhibitor perindopril.

Sihm I, Schroeder AP, Aalkjaer C, Holm M, Mørn B, Mulvany M, Thygesen K, Lederballe O.

Blood Press. 1995 Jul;4(4):241-8.

PMID:
7496564
26.

Silent myocardial ischaemia in untreated essential hypertensives.

Schroeder AP, Brysting B, Søgaard P, Pedersen OL.

Blood Press. 1995 Mar;4(2):97-104.

PMID:
7599761
27.

Normalization of resistance artery structure and left ventricular morphology with a perindopril-based regimen.

Sihm I, Schroeder AP, Aalkjaer C, Holm M, Mørn B, Mulvany M, Thygesen K, Pedersen OL.

Can J Cardiol. 1994 Nov;10 Suppl D:30D-32D.

PMID:
7954038
28.

[Regression of hypertensive cardiovascular changes during treatment with antihypertensive ddrugs].

Schroeder AP, Pedersen OL.

Ugeskr Laeger. 1992 Nov 9;154(46):3230-6. Review. Danish.

PMID:
1462424
29.

[Cardiovascular changes in arterial hypertension].

Schroeder AP, Pedersen OL.

Ugeskr Laeger. 1992 Nov 9;154(46):3226-9. Review. Danish.

PMID:
1462423

Supplemental Content

Loading ...
Support Center